These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 1085665)

  • 41. Frequency, serodiagnosis and epidemiological features of subacute sclerosing panencephalitis (SSPE) and epidemiology and vaccination policy for measles in the Federal Republic of Germany (FRG).
    Enders-Ruckle G
    Dev Biol Stand; 1978; 41():195-207. PubMed ID: 381072
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Progress in measles control--Kenya 2002-2007.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2007 Sep; 56(37):969-72. PubMed ID: 17882128
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Epidemiologic and clinical effect of measles vaccination in Karl-Marx City District. II].
    Hajduk F; Starke G; Grimm J
    Dtsch Gesundheitsw; 1970 Oct; 25(44):2095-6. PubMed ID: 5491297
    [No Abstract]   [Full Text] [Related]  

  • 44. Combination of attenuated measles vaccine (Schwarz) with meningococcus A and A + C vaccine.
    Ajjan N; Fayet MT; Biron G; Charbonnier C; Nicolas A; Triau R; Roumiantzeff M
    Dev Biol Stand; 1978; 41():209-16. PubMed ID: 111980
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prevalence of IgG antibody against measles, mumps and rubella in bangladeshi children: a pilot study to evaluate the need for integrated vaccination strategy.
    Sultana R; Rahman MM; Hassan Z; Hassan MS
    Scand J Immunol; 2006 Dec; 64(6):684-9. PubMed ID: 17083626
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Measles vaccination: revised recommendations for immunization.
    Reece SM
    Nurse Pract; 1990 Dec; 15(12):19-20, 23-4. PubMed ID: 2284058
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Measles control in Maputo, Mozambique, using a single dose of Schwarz vaccine at age 9 months.
    Cutts FT; Monteiro O; Tabard P; Cliff J
    Bull World Health Organ; 1994; 72(2):227-31. PubMed ID: 8205642
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Measles epidemiology and outbreak response immunization in a rural community in Peru.
    Sniadack DH; Moscoso B; Aguilar R; Heath J; Bellini W; Chiu MC
    Bull World Health Organ; 1999; 77(7):545-52. PubMed ID: 10444877
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Measles and mumps immunization: benefit versus risk factors.
    Krugman S
    Dev Biol Stand; 1979; 43():253-7. PubMed ID: 520672
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The epidemiology of measles in England and Wales since the 1994 vaccination campaign.
    Gay N; Ramsay M; Cohen B; Hesketh L; Morgan-Capner P; Brown D; Miller E
    Commun Dis Rep CDR Rev; 1997 Feb; 7(2):R17-21. PubMed ID: 9046124
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The status of measles after five years of mass vaccination in the USSR.
    Burgasov PN; Andzaparidze OG; Popov VF
    Bull World Health Organ; 1973; 49(6):571-6. PubMed ID: 4548384
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Experience with the production, control and use of live measles vaccine L-16 SSW].
    Shtarke G; Khlinak R
    Vopr Virusol; 1968; 13(6):724-9. PubMed ID: 5753361
    [No Abstract]   [Full Text] [Related]  

  • 53. [An epidemiologic analysis of the effectiveness of immunization against measles thoughout the year following the vaccination campaign].
    Shtarke G; Glinak P; Graneĭs Kh
    Zh Mikrobiol Epidemiol Immunobiol; 1969 Sep; 46(9):46-9. PubMed ID: 5357666
    [No Abstract]   [Full Text] [Related]  

  • 54. Evaluation of measles vaccination programme conducted in two separate health centres.
    Onoja AL; Adu FD; Tomori O
    Vaccine; 1992; 10(1):49-52. PubMed ID: 1539460
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Reactogenic properties and immunologic effectiveness of several series of live Leningrad-16 measles vaccine used for mass immunization of children].
    Zetilova LP; Zargar'iants AI; Bolotovskiĭ VM; Titova NS; Derzhavina TA
    Zh Mikrobiol Epidemiol Immunobiol; 1976 Jan; (1):144-5. PubMed ID: 961234
    [No Abstract]   [Full Text] [Related]  

  • 56. [Measles immunization in the Dresden district].
    Heidel G; Beuthin K; Laesch W; Winter K
    Z Arztl Fortbild (Jena); 1975 Jun; 69(12):624-31. PubMed ID: 7045
    [No Abstract]   [Full Text] [Related]  

  • 57. Expanded programme on immunization (EPI). The Measles Elimination Programme.
    Wkly Epidemiol Rec; 1994 May; 69(21):157-9. PubMed ID: 8049121
    [No Abstract]   [Full Text] [Related]  

  • 58. Flawed analysis of limited data led to an incorrect conclusion that a measles immunization campaign in the Lao People's Democratic Republic had minimal impact.
    Mansoor O; Bassett D; McFarland J; Baoping Y; Omi S
    J Epidemiol; 2002 Jul; 12(4):341-2; author reply 342-3. PubMed ID: 12395876
    [No Abstract]   [Full Text] [Related]  

  • 59. [Lessons of an experimental campaign of vacination against measles in the urban environment].
    Rey M; Cantrelle P; Lafaix C; Mar ID; Sow A; Agboton Y
    Bull Soc Med Afr Noire Lang Fr; 1968; 13(2):291-310. PubMed ID: 5713773
    [No Abstract]   [Full Text] [Related]  

  • 60. Association of Previous Measles Infection With Markers of Acute Infectious Disease Among 9- to 59-Month-Old Children in the Democratic Republic of the Congo.
    Ashbaugh HR; Cherry JD; Hoff NA; Doshi RH; Alfonso VH; Gadoth A; Mukadi P; Higgins SG; Budd R; Randall C; Okitolonda-Wemakoy E; Muyembe-Tamfum JJ; Gerber SK; Rimoin AW
    J Pediatric Infect Dis Soc; 2019 Dec; 8(6):531-538. PubMed ID: 30346573
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.